Compartilhar
Informação da revista

Os mais lidos

3272
Chronic lymphocytic leukemia diagnosis: how many more algorithms and scoring systems do we need?
Daniel Mazza Matos
Hematol Transfus Cell Ther. 2025;47:3668
3272
Acesso de texto completo
3258
Diagnosis and treatment of chronic lymphocytic leukemia: 2025 recommendations of the Brazilian Group of Chronic Lymphocytic Leukemia of the Brazilian Association of Hematology and Hemotherapy (ABHH)
Carlos Sérgio Chiattone, Fernanda de Morais Marques, Valeria Buccheri, Mihoko Yamamoto, Sergio Costa Fortier, Maura Rosane Valerio Ikoma-Colturato, Nelson Hamerschlak, Vera Lucia de Piratininga Figueiredo, ... Brazilian Group of Chronic Lymphocytic Leukemia
Hematol Transfus Cell Ther. 2025;47:103822
3258
Acesso de texto completo
3141
Ponatinib in the treatment of patients with chronic myeloid leukemia and increased cardiovascular risk: A review of management strategies
Tomasz Sacha, Katarzyna Krawczyk
Hematol Transfus Cell Ther. 2025;47:3675
3141
Acesso de texto completo
3069
An approach to autologous stem cell mobilization: trying to define good mobilizers
Sara Montolio Chiva, Paula Gomez Fernandez, Antonio Manuel Gutiérrez Garcia, Maria del Carmen Ballester Ruiz, Antonia Sampol Mayol, Albert Perez Montaña
Hematol Transfus Cell Ther. 2025;47:3688
3069
Acesso de texto completo
2989
When innovation meets patient blood management – a new way to see bleeding
Guilherme Rabello, Rosangela Monteiro, Bianca Meneghini, Fabio Biscegli Jatene
Hematol Transfus Cell Ther. 2025;47:3691
2989
Acesso de texto completo
2236
Is galactomannan a useful tool for triage and diagnosis of oral invasive aspergillosis?
Maria Júlia Pagliarone, Lara Maria Alencar Ramos Innocentini, Fernanda Bortolotto, Vanessa Tonetto Marques Galves, Hilton Marcos Alves Ricz, Tatiane Cristina Ferrari, Renato Luiz Guerino Cunha, Belinda Pinto Simões, Leandro Dorigan de Macedo
Hematol Transfus Cell Ther. 2025;47:3687
2236
Acesso de texto completo
2216
From the mechanism of action to clinical management: A review of cardiovascular toxicity in adult treated with CAR-T therapy
Frank Nunes, Breno Moreno de Gusmão, Franciely Bueno Wiginesk, Euler Manenti, Juliana Soares, Mizianne Garcia Freitas, Juliane Dantas Seabra-Garcez, Alexandre Manoel Varela, ... Ariane Vieira Scarlatelli Macedo
Hematol Transfus Cell Ther. 2025;47:3693
2216
Acesso de texto completo
1976
Optimization of hydroxyurea in sickle cell disease in Brazil
Clarisse Lobo, Ana Cristina Silva-Pinto, Rodolfo Delfini Cançado
Hematol Transfus Cell Ther. 2025;47:103826
1976
Acesso de texto completo
1930
Blood storage effect of G6PD on RBC quality
Andrew Evans Cobbinah, Benedict Sackey, Mina Ofosu, Herbert Ekoe Dankluvi, Stephen Opoku, Ampa Davis Frank
Hematol Transfus Cell Ther. 2025;47:103733
1930
Acesso de texto completo
1925
Lower doses of dacarbazine (modified BEACODD) as a safer strategy with equal effectiveness in an intensive treatment protocol of Hodgkin's lymphoma: a preliminary retrospective analysis of a single public center in Brazil
Larissa Hilario Dulley, Arthur Gomes Oliveira Braga, Guilherme Garcia Rodrigues, Sergio Costa Fortier, Carlos Sérgio Chiattone, Talita Maira Bueno da Silveira
Hematol Transfus Cell Ther. 2025;47:3682
1925
Acesso de texto completo
1852
Validation of an automated quality control method to test sterility of two advanced therapy medicinal products: Mesenchymal stromal cells and their extracellular vesicles
Carolina Kymie Vasques Nonaka, Zaquer Suzana Munhoz Costa-Ferro, Ana Carolina Palmeira Arraes, Thamires Lopes Weber, Luciana Souza de Aragão França, Katia Nunes Silva, Bruno Solano de Freitas Souza
Hematol Transfus Cell Ther. 2025;47:3727
1852
Acesso de texto completo
1732
Complex somatic mutation landscape in myeloid cells in a patient with VEXAS syndrome: First Brazilian case report
Fabíola Reis de Oliveira, Adriane Souza Lima, Carlos Roberto Faria, Thaise Oliveira Quaresma, Marcio M. Mourani, Lauro Wichert-Ana, Paulo Louzada, Fernanda Gutierrez-Rodrigues, ... Rodrigo T. Calado
Hematol Transfus Cell Ther. 2025;47:3686
1732
Acesso de texto completo
1583
Annualized bleeding rate in hemophilia A patients in Brazil: a systematic review
Alessandra NL Prezotti, Débora MC Rocha, Endi L. Galvão, Thaís Gimenez, Leo Sekine, Rodrigo A. Ribeiro, Elisa Sobreira
Hematol Transfus Cell Ther. 2025;47:103736
1583
Acesso de texto completo
1566
Impact of blueberry extract on hematological response in phenylhydrazine-induced hemolytic anemia
Daniela Drosdowski, Patrick Türck, Silvio Tasca, Gabriel de Lima Rosa, Edson Fernando Muller Guzzo, Sara Elis Bianchi, Adriana Simon Coitinho, Cristina Campos Carraro, ... Alex Sander da Rosa Araujo
Hematol Transfus Cell Ther. 2025;47:103744
1566
Acesso de texto completo
1498
STAT5B::RARα-positive acute promyelocytic leukemia: Role of next generation sequencing in detection of a rare malignancy
Indranil Dey, Sushant Vinarkar, Mayur Parihar, Deepak Kumar Mishra
Hematol Transfus Cell Ther. 2025;47:3726
1498
Acesso de texto completo
1311
Transmitted blood infections and emerging vector-borne diseases in blood donors in northern Portugal
Ana Mota, Margarida Fonseca Cardoso
Hematol Transfus Cell Ther. 2025;47:103734
1311
Acesso de texto completo
1255
Assessing the role of bronchoscopy in the management of patients with acute leukemia—a transversal study and proposal of evaluation
José Vanildo Rodrigues de Oliveira, Carlos Wilson de Alencar Cano, José Vivaldo Moreira Feitosa Júnior, Guilherme Carneiro Barreto, Fernanda Rodrigues Mendes, Raphael Costa Bandeira de Melo, Elvira Deolinda Rodrigues Pereira Velloso, Vanderson Rocha, ... Wellington Fernandes da Silva
Hematol Transfus Cell Ther. 2025;47:103741
1255
Acesso de texto completo
1152
A common ground: an in silico assessment of the sources of intrinsic ex vivo resistance to venetoclax in acute myeloid leukemia
Brunno Gilberto Santos de Macedo, Manuela Albuquerque de Melo, Diego Antonio Pereira-Martins, João Agostinho Machado-Neto, Fabiola Traina
Hematol Transfus Cell Ther. 2025;47:103758
1152
Acesso de texto completo
1140
Rare case of discrepant ABO typing between mother and newborn caused by para-Bombay AB phenotype
Tatiane Aparecida de Paula Vendrame, Giovana Faria Devides, Nayara Morais Silva, Marcela Custódio Mendes, Márcia Léia Morais Sampaio, Marcia Miyuki Nakamura, Greice Ap.Chetta de Klerk, Lilian Castilho, ... Carine Prisco Arnoni
Hematol Transfus Cell Ther. 2025;47:103742
1140
Acesso de texto completo
1125
Outcomes and vaccination patterns against COVID-19 in a cohort of sickle cell disease patients in the state of Rio de Janeiro
Claudia de Alvarenga Maximo, Jorge Francisco da Cunha Pinto, Fabiana Canedo Pinto, Patrícia Brasil
Hematol Transfus Cell Ther. 2025;47:103824
1125
Acesso de texto completo
Idiomas
Hematology, Transfusion and Cell Therapy